CAS: 66176-39-4; 4-(Bromomethyl)Benzenesulfonyl Chloride

该化合物是一种用于有机合成的多用途灭蚁基和烷基试剂,其主要结构特征--一种反应性苯基溴和全氟化碳组--在目标分子中引入磺酰和溴甲基甲状腺的双重功能,该化合物对于编制磺酰胺衍生物,聚合物中间体和制药建筑构件特别宝贵,苯基溴为核生殖替代或交叉相交反应提供了进一步的再活性,而磺酰氯则在温和条件下促进高效的磺化,在受控储存条件下和高纯度使其成为需要精确功能化的合成应用的可靠选择.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

p-toluenesulfonyl chloride azobisisobutyronitrile 4-bromo-benzaldehyde phenylmethanethiol 4-bromomethyl-benzenesulfonamide 4-bromomethyl-benzenesulfonic acid methyl ester 4-(bromomethyl)benzenesulfonic acid 4-(bromomethyl)-N,N-diethylbenzenesulfonamide

合成工艺路线路线简述

    对甲苯磺酰氯置于n-溴代丁二酰亚胺(Nbs)体系中,用 四氯化碳 作为反应溶剂,化学反应生成 4-溴甲基苯磺酰氯
    参考文献:一系列新的选择性白三烯拮抗剂:探索和优化1,6-二取代的吲哚和吲唑的酸性区域.
    标题:一系列新的选择性白三烯拮抗剂:探索和优化1,6-二取代的吲哚和吲唑的酸性区域.
    摘要:对一系列由吲哚或吲唑衍生的白三烯拮抗剂1的羧酸区域进行系统的结构活性探索导致了一些发现.使用3-甲氧基对甲苯基片段(如酸1中所示)连接吲哚和酸性位点可提供最有效的羧酸1,四唑20和芳基磺酰亚胺21.芳基磺酰亚胺的含量是5-500倍以上(在体外和/或体内)比相应的羧酸更有效.在给定的体外活性水平下,邻甲苯基磺酰亚胺(如114)显示出比苯基磺酰亚胺更大的口服效力.酸性酮砜衍生物10(nu = Ch-(co2Ch3)so2Ph)模拟了磺酰亚胺的活性.
    DOI:10.1021/jm00171A018

    海关参考信息

    专利信息


    专利号:US-2013203709-A1
    优先权日:2010-08-09
    标 题 :Acylsulfonamides and processes for producing the same
    发明人:MANETSCH ROMAN; KULKARNI SAMEER; IYAMU IREDIA D; WANG HONG-GANG; DOI KENICHIRO; GUIDA WAYNE; SANTIAGO DANIEL; DU BOULAY COURTNEY
    权利人:MANETSCH ROMAN; KULKARNI SAMEER; IYAMU IREDIA D; WANG HONG-GANG; DOI KENICHIRO; GUIDA WAYNE; SANTIAGO DANIEL; DU BOULAY COURTNEY; PENN STATE RES FOUND; UNIV SOUTH FLORIDA
    摘要:The present disclosure relates to acylsulfonamides and processes for their preparation. The processes involve a target-guided synthesis approach, whereby a thioacid and a sulfonyl azide are reacted in the presence of a biological target protein, a Bcl-2 family protein, to form the acylsulfonamide.

    专利号:US-2014315915-A1
    优先权日:2009-02-09
    标题:Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs

    专利号:CN-117551005-A
    优先权日:2022-08-05
    标题 :A kind of synthesis method of 2-bromobenzenesulfonyl chloride and its derivatives

    专利号:US-8524947-B2
    优先权日:2008-02-22
    标题 :Acylsulfonamides and processes for producing the same
    发明人:WANG HONG-GANG; MANETSCH ROMAN; HU XIANGDONG; KULKARNI SAMEER; SUN JIAZHI
    权利人:WANG HONG-GANG; MANETSCH ROMAN; HU XIANGDONG; KULKARNI SAMEER; SUN JIAZHI; UNIV SOUTH FLORIDA; H LEE MOFFITT CANCER CT & RES
    摘要:The present disclosure relates to acylsulfonamides and processes for their preparation. The processes involve a target-guided synthesis approach, whereby a thioacid and a sulfonyl azide are reacted in the presence of a biological target protein, a Bcl-2 family protein, to form the acylsulfonamide.

    专利号:US-9643960-B2
    优先权日:2009-02-09
    标 题:Procaspase activating compounds
    发明人:HERGENROTHER PAUL J; PETERSON QUINN PATRICK; HSU DANNY CHUNG; WEST DIANA C; FAN TIMOTHY M; NOVOTNY CHRIS J
    权利人:UNIV ILLINOIS
    摘要:Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed that have lower neurotoxicity effects than other compounds.

    专利号:US-2012040995-A1
    优先权日:2009-02-09
    标 题:Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
    上海凌凯医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.linkchem.cn
    企业联系电话:021-58950110;13124863828👤
    📞上海凌凯医药科技有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:021-58950110;13124863828
    手机:13124863828
    传真:021- 2096 2272
    邮箱:sales@linkchem.cn
    通信地址: 上海市浦东新区国际医学园区康新公路3399弄5号楼
    邮编: 201204
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市浦东新区国际医学园区康新公路3399弄5号楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Suazette Reid Mooring, Et Al. Benzenesulfonamides: A Unique Class Of Chemokine Receptor Type 4 Inhibitors. Chemmedchem. 2013 Apr;8(4):622-32.

    合成参考文献


    参考文献:10.1007/s00044-025-03507-0
    摘要:Lozinskaya N, Krylov N, Vinogradova D, Efremov A, Beznos O, Salykina M, Naumenko L, Taran A, Cheban’ko A, Veselov I, Sosonyuk S, Spasov A, Shevtsova E. Sulfonamide-substituted oxindoles as inhibitors of carbonic anhydrase II with potential antiglaucoma activity. Med Chem Res. 2025 Nov 24;35(1):147–63. doi: 10.1007/s00044-025-03507-0.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知